Francesco Bianchi Sells 1,650 Shares of LivaNova (NASDAQ:LIVN) Stock

Key Points

• Director Francesco Bianchi sold 1,650 LivaNova shares at an average price of $79.72, generating $131,538 and reducing his direct ownership by 17.22% to 7,934 shares.
• LivaNova shares rose 2.8% to $82.40, while the company’s latest quarterly results exceeded expectations with adjusted EPS of $1.26 and revenue of $390.59 million, up 10.8% year over year.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $84.12; institutional investors collectively own 97.64% of the company.

LivaNova PLC (NASDAQ:LIVN - Get Free Report) Director Francesco Bianchi sold 1,650 shares of the business's stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $79.72, for a total value of $131,538.00. Following the completion of the sale, the director directly owned 7,934 shares in the company, valued at approximately $632,498.48. This represents a 17.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

LivaNova Stock Up 2.8%

LIVN stock traded up $2.24 on Wednesday, reaching $82.40. 769,445 shares of the company traded hands, compared to its average volume of 760,159. The firm has a fifty day simple moving average of $80.67 and a 200-day simple moving average of $72.59. The company has a market cap of $4.54 billion, a P/E ratio of 24.38 and a beta of 0.86. LivaNova PLC has a one year low of $48.82 and a one year high of $85.76. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.45 and a quick ratio of 1.21.

LivaNova (NASDAQ:LIVN - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.09 by $0.17. The firm had revenue of $390.59 million for the quarter, compared to analysts' expectations of $380.50 million. LivaNova had a return on equity of 16.35% and a net margin of 12.82%.The company's quarterly revenue was up 10.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.05 earnings per share. Research analysts anticipate that LivaNova PLC will post 3.77 earnings per share for the current year.

Analyst Upgrades and Downgrades

LIVN has been the subject of several recent analyst reports. Needham & Company LLC lifted their target price on shares of LivaNova from $81.00 to $93.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Freedom Capital upgraded shares of LivaNova to a "hold" rating in a report on Tuesday, June 30th. Mizuho raised their price target on shares of LivaNova from $90.00 to $95.00 and gave the company an "outperform" rating in a research report on Wednesday, July 15th. Stifel Nicolaus set a $85.00 price objective on shares of LivaNova in a report on Wednesday, August 5th. Finally, Robert W. Baird lowered their price objective on LivaNova from $78.00 to $76.00 and set an "outperform" rating on the stock in a research report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $84.12.

Hedge Funds Weigh In On LivaNova

A number of hedge funds have recently bought and sold shares of LIVN. UMB Bank n.a. boosted its stake in shares of LivaNova by 22.6% during the 4th quarter. UMB Bank n.a. now owns 971 shares of the company's stock worth $60,000 after acquiring an additional 179 shares during the last quarter. State of Michigan Retirement System increased its stake in shares of LivaNova by 1.5% in the 1st quarter. State of Michigan Retirement System now owns 13,111 shares of the company's stock worth $833,000 after purchasing an additional 200 shares in the last quarter. Hantz Financial Services Inc. increased its stake in shares of LivaNova by 159.9% in the 4th quarter. Hantz Financial Services Inc. now owns 434 shares of the company's stock worth $27,000 after purchasing an additional 267 shares in the last quarter. GAMMA Investing LLC raised its holdings in LivaNova by 18.2% in the 2nd quarter. GAMMA Investing LLC now owns 1,838 shares of the company's stock worth $151,000 after purchasing an additional 283 shares during the period. Finally, Parallel Advisors LLC lifted its position in LivaNova by 28.8% during the fourth quarter. Parallel Advisors LLC now owns 1,266 shares of the company's stock valued at $78,000 after purchasing an additional 283 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company's primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source